By iData Research Analyst Fallyn Thompson

The prevailing trend in the United States Dialysis market is the lack of movement towards home care. Despite industry encouragement, patients – whether by choice or eligibility – feel safer choosing in-center treatment options with the benefit of trained medical professionals on site. The market trend projects a small transition from in-center hemodialysis machine sales to a combination of home hemodialysis and peritoneal dialysis machine sales from 2016-2023. Marketing campaigns will benefit from a renewed focus towards traditional means of dialysis over a 5 year projection; to optimize future sales and market share.

In an exceptionally stable and established market, the shift of patients between short and long term catheters, AV fistulas and AV access grafts is an exciting change, improving patient safety. The increase in AV fistula units sold is accredited to the Fistula First Breakthrough Initiative, launched in 2003. At the one year mark for new hemodialysis patients, the initiative has achieved substantial results evident in the unit sales. The challenge is understanding the demographics that drive and limit when a patient receives an AV fistula in the first year of treatment and how to negate the waiting period. The combined market value of catheters, AV fistulas and AV access grafts will continue to reallocate exponentially over a five year projection.


The dialysis market is experiencing subtle yet critical trends as the number of patients requiring hemodialysis continues to increase. As patient numbers reach an all-time high, the industry is also plagued with falling profit margins. With Medicare reimbursement being increasingly cut and shrinking margins for dialysis facilities year over year, strategic growth has never been more important. Dialysis treatment facilities are rapidly turning into monopolies and dialysis manufacturers are adapting to a new environment; with sole-partnership agreements and specialization through portfolio acquisitions becoming increasingly prevalent. Instead of diversifying, manufacturers are best poised to achieve future success in the United States dialysis market through specialized skill-sets and products.

About the Author

Fallyn Thompson is the lead research analyst at iData Research for global gynecological device markets encompassing the U.S., Asia-Pacific, and 15 countries in Europe.

About iData Research

iData Research is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: diabetes drugs, diabetes devices, pharmaceuticals, anesthesiology, wound management, orthopedics, cardiovascular, ophthalmics, endoscopy, gynecology, urology, and more.


  1. US Market Report Suite for Dialysis Devices and Concentrates 2017 – MedSuite – 2016, iData Research Inc. Accessed Nov. 29, 2016